Genomics Intelligence company Human Longevity, Inc. (HLI) announced Scott Sorensen as it chief technology officer, reporting to J. Craig Venter, Ph.D., co-founder, chairman and CEO. Sorensen joins HLI from consumer genomics company Ancestry where he held a variety of positions during his 16-year career.
At Ancestry Sorensen helped develop the strategy that saw the company transform from a family history business into a genomics business. He directed the development of scalable, reliable technology platforms and architecture – and created processes for engineers and scientists to collaborate and deliver solutions to clients effectively.
“The genome codes for our past and our future–our family history and our possible health risks. Scott shares our vision that connecting people with their personal health information in accessible ways is key to precision medicine,” said Venter in a press release. “At HLI, we are poised to deliver Health Nucleus products and services globally, and we know Scott's technical and business experience is critical to help us enhance and deliver the insightful power of the genome to our clients
Sorensen joins HLO at a time when the company plans to expand its Health Nucleus program to locations across the country and around the world, and enhance this product with more digital, consumer friendly interfaces. HLI also continues to expand its database of whole genome, phenotype and clinical data, analyzed by its esteemed group of bio-informatic scientists to generate discoveries to improve individual and population health and our understanding of the genome.
“The integration of genomics and technology, paired with machine learning as pioneered at HLI and the Health Nucleus, is certain to be the starting point of healthcare in the not too distant future, and I'm excited to be part of the team helping to transform medicine in this way to benefit clients and their families,” said Sorensen.